Effectiveness of Virtual Reality Training on Unilateral Spatial Neglect After Stroke (NCT04714645) | Clinical Trial Compass
UnknownNot Applicable
Effectiveness of Virtual Reality Training on Unilateral Spatial Neglect After Stroke
Belgium40 participantsStarted 2021-02-15
Plain-language summary
The aim of this study is to examine the effect of an additional VR training program on unilateral spatial neglect (USN) after stroke. Principally, clinical assessment of the presence of unilateral spatial neglect and additionally the severity of USN will be measured using the Behavioral Inattention test (BIT), using only the BIT Conventional subtest (BITC). Secondarily, the VR outcomes will be included as well.
Finally, we want to determine if the effects last over a short period of time. It is important to know whether the potential effects of the VR-training remain without continuing the intervention. Therefore, we will perform a follow-up assessment after 1 week.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* a right-hemisphere hemorrhagic or ischemic stroke, confirmed by CT or MRI
* only subacute (\>2 weeks) and chronic (\>6 months) unilateral spatial neglect patients
* scoring below the cut-off value of 129 points on the standard BITC test
* being 18 years or older at the time of lesion
Exclusion Criteria:
* patients with dementia (Mini Mental State Examination (MMSE) \< 24) or aphasia (Mississippi Aphasia Screening Test (MAST) \< 45)
* patients whose visual or hearing impairment does not allow possibility of interaction with the VR system
* patients with depression (Patient Health Questionnaire (PHQ-9) \>= 10)
* patients unable to sit for at least 30 minutes in a wheelchair or chair
* patients with sensorimotor alterations that can interfere with the performance with the VR system
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.